Biologics License Application acceptance supported by results from the Phase 3 Vivacity-MG3 study Results demonstrate sustained disease control over 24 weeks in a broad ...

CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells causing Lupus. First approved for treating leukemia in 2017, CAR-T cell therapy ...

All women produce a small amount of testosterone - the hormone that is responsible for baldness in men. It comes from both the ovaries, and also the adrenal glands. Up until the menopause, the ...

Peter Chin-Hong, an infectious disease specialist at UC San Francisco, said people should be on the lookout for the “Big Four”: three respiratory viruses currently moving through the U.S ...

By that night, Republicans had shot down the budget proposal — and with it any hope that Musk and Vivek Ramaswamy's Department of Government Efficiency (abbreviated, annoyingly, as DOGE ...

It's conference champ versus conference champ for the 2024 Cure Bowl as Conference USA champion ... Well, these aren't just any ol' conference champs, they both decimated their opponents in ...

Back to Healio WASHINGTON — A phase 1/2 study of CD19 chimeric antigen receptor T-cell therapy in lupus and other autoimmune diseases demonstrated ... to Schett, the treatment yielded “very ...

Above all, exploring this frontier in microbiota research not only promises to highlight the underpinnings of immune dysregulation but also to revolutionize the treatment paradigms for autoimmune ...

Color blindness is also known as color vision deficiency, and there’s currently no cure for it ... stationary night blindness is a retinal disease. It affects various aspects of vision and ...